Meyer Andrew Hollman
Chief Business Officer · 9 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-02 | JANX | Janux Therapeutics, Inc. | Sale | 1,879 | $13.73 | $25,798.67 | filing |
| 2025-12-01 | JANX | Janux Therapeutics, Inc. | Sale | 2,700 | $32.85 | $88,707.96 | filing |
| 2025-12-01 | JANX | Janux Therapeutics, Inc. | Option exercise | 3,333 | $10.59 | $35,296.47 | filing |
| 2025-12-01 | JANX | Janux Therapeutics, Inc. | Sale | 633 | $33.52 | $21,221.14 | filing |
| 2025-11-14 | JANX | Janux Therapeutics, Inc. | Sale | 3,333 | $30.00 | $99,990.00 | filing |
| 2025-11-14 | JANX | Janux Therapeutics, Inc. | Option exercise | 3,333 | $10.59 | $35,296.47 | filing |
| 2025-10-28 | JANX | Janux Therapeutics, Inc. | Sale | 16,665 | $30.06 | $500,986.56 | filing |
| 2025-10-28 | JANX | Janux Therapeutics, Inc. | Option exercise | 6,666 | $10.59 | $70,592.94 | filing |
| 2025-10-28 | JANX | Janux Therapeutics, Inc. | Option exercise | 9,999 | $4.21 | $42,095.79 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.